CompletedPhase 2NCT01941966

A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.

Studying Carcinoma of the anal canal

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto do Cancer do Estado de São Paulo
Principal Investigator
Paulo MG Hoff, PHD
Instituto do Cancer do Estado de São Paulo
Intervention
Capecitabine(drug)
Enrollment
51 enrolled
Eligibility
18 years · All sexes
Timeline
2010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01941966 on ClinicalTrials.gov

Other trials for Carcinoma of the anal canal

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the anal canal

← Back to all trials